Panacea Life Sciences HOLDINGS, Inc. (PLSH) intrinsic value & 10-year financials
Panacea Life Sciences HOLDINGS, Inc. (PLSH) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 141.6% a year to $2.4M, with an average return on invested capital of 4.8%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.07
- Market cap
- $1.1M
- Revenue (FY2023)
- $2.4M
- Revenue growth (10-yr CAGR)
- 141.6%
- ROIC (10-yr avg)
- 4.8%
- Free cash flow (FY2023)
- -$1.6M
PLSH 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2023 | $2.4M | -$8.0M | -$0.48 | -$1.6M | -232.5% | 372.6% |
| FY2022 | $1.6M | -$9.1M | -$0.62 | -$2.6M | -347.4% | -162.3% |
| FY2021 | $2.1M | -$4.8M | — | -$4.1M | -288.3% | -117.0% |
| FY2020 | $2.1M | -$10.9M | — | -$692.3K | -509.7% | -527.6% |
| FY2019 | $345.7K | -$10.2M | — | -$6.3M | -3147.0% | -573.6% |
| FY2018 | $0 | -$4.3M | — | -$465.8K | — | 94.5% |
| FY2017 | $0 | -$3.9M | — | — | — | 333.4% |
| FY2016 | $0 | -$1.6M | — | -$892.2K | — | -360.1% |
| FY2015 | $213 | -$358.0K | — | -$640.0K | -182661.5% | 1636.3% |
| FY2014 | $852 | -$296.6K | — | -$405.7K | -49326.1% | -648.0% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
PANACEA LIFE SCIENCES HOLDINGS, INC. is a consistent compounder, expanding top-line revenue at 141.5% annually over the past decade.
PANACEA LIFE SCIENCES HOLDINGS, INC. has historically struggled to out-earn its cost of capital, averaging just -2.2% ROIC.
PANACEA LIFE SCIENCES HOLDINGS, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, PANACEA LIFE SCIENCES HOLDINGS, INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-15.94 per share.